No Detail Found!

Comparative Efficacy and safety profile of 5 mg rosuvastatin Versus 10 mg rosuvastatin in patients with ischemic heart disease.

Author(s)
M. Abid Shah Department of Pharmacology, Khyber Medical College, Peshawar, Pakistan
Shams Suleman Department of Pharmacology, Khyber Medical College, Peshawar, Pakistan
Asif Hussain Munir Department of Pathology, Khyber Medical College, Peshawar, Pakistan
Abstract
Objectives: To compare the efficacy and clinical profile of 5 mg rosuvastatin versus 10 mg rosuvastatin in improving the management of patients with IHD. Material and Methods: This study was jointly conducted by Department of Pharmacology, Khyber Medical College, and Cardiology Department of Khyber Teaching Hospital from January 2011 to August 2011. The patients presenting to coronary care unit and cardiology OPD were randomized into a two groups; Group A and Group B each comprising 50 patients. Group A recieved 5 mg of rosuvastatin and Group B received 10 mg of resovuastatin for three months. National cholesterol Education programme adult treat panel III (NCEP ATP III) guideline for LDL-C was chosen as the primary objective while assessing the safety profile and toxicity was considered the secondary end point. A rise in HDL-C was also anticipated. Results: Thirty-four (68%) patients in group A and 41 (82%) patients in group B were male. All the patients were resident of Peshawar. Their mean ages were 51.4 7.6 and 49.35 5.65 years respectively in group A and B. The LDL-C dropped to NCEP ATP III value of
Publication Details
Page(s) 35-39
DOI DOI not available
Published Journal: Journal of Medical Science, Volume: 21, Issue: 1, Year: 2013

Request the full text from PASTIC

0

Citations

0

Downloads

38

Views